No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr9:98111000-98112400 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
2 |
chr9:98111000-98112800 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
3 |
chr9:98111200-98112200 |
Bivalent/Poised TSS |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
4 |
chr9:98111200-98112200 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|
5 |
chr9:98111200-98112400 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
6 |
chr9:98111200-98112400 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
7 |
chr9:98111200-98112600 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
8 |
chr9:98111200-98112600 |
Bivalent/Poised TSS |
H1 Cell Line |
embryonic stem cell
|
9 |
chr9:98111200-98112600 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
10 |
chr9:98111200-98112600 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
11 |
chr9:98111200-98112600 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
12 |
chr9:98111200-98112800 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
13 |
chr9:98111400-98112200 |
Bivalent/Poised TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
14 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
15 |
chr9:98111400-98112200 |
Bivalent/Poised TSS |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
16 |
chr9:98111400-98112200 |
Flanking Active TSS |
Primary T helper naive cells fromperipheralblood |
blood
|
17 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
18 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
19 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
20 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
Brain Germinal Matrix |
brain
|
21 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
Esophagus |
oesophagus
|
22 |
chr9:98111400-98112200 |
Bivalent/Poised TSS |
Fetal Intestine Large |
intestine
|
23 |
chr9:98111400-98112200 |
Bivalent Enhancer |
Sigmoid Colon |
Sigmoid Colon
|
24 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
Stomach Smooth Muscle |
stomach
|
25 |
chr9:98111400-98112200 |
Bivalent/Poised TSS |
Thymus |
Thymus
|
26 |
chr9:98111400-98112200 |
Active TSS |
HepG2 |
liver
|
27 |
chr9:98111400-98112200 |
Flanking Bivalent TSS/Enh |
HMEC |
breast
|
28 |
chr9:98111400-98112200 |
Bivalent/Poised TSS |
NHEK |
skin
|
29 |
chr9:98111400-98112400 |
Bivalent/Poised TSS |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
30 |
chr9:98111400-98112400 |
Bivalent/Poised TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
31 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|
32 |
chr9:98111400-98112400 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
33 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
34 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
35 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
36 |
chr9:98111400-98112400 |
Enhancers |
Liver |
Liver
|
37 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
Colonic Mucosa |
Colon
|
38 |
chr9:98111400-98112400 |
Bivalent/Poised TSS |
Duodenum Smooth Muscle |
Duodenum
|
39 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
Fetal Stomach |
stomach
|
40 |
chr9:98111400-98112400 |
Flanking Active TSS |
Ovary |
ovary
|
41 |
chr9:98111400-98112400 |
Flanking Bivalent TSS/Enh |
Placenta Amnion |
Placenta Amnion
|
42 |
chr9:98111400-98112400 |
ZNF genes & repeats |
Spleen |
Spleen
|
43 |
chr9:98111400-98112600 |
Bivalent/Poised TSS |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
44 |
chr9:98111400-98112600 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
45 |
chr9:98111400-98112600 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
46 |
chr9:98111400-98112600 |
Flanking Bivalent TSS/Enh |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
47 |
chr9:98111400-98112800 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
48 |
chr9:98111600-98112200 |
Bivalent/Poised TSS |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
49 |
chr9:98111600-98112200 |
Bivalent/Poised TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
50 |
chr9:98111600-98112200 |
Bivalent Enhancer |
Primary hematopoietic stem cells short term culture |
blood
|